Gender Differences May Exist in the Presentation, Mechanism of Injury and Outcomes Following Bone Marrow Stimulation for Osteochondral Lesions of the Talus

Bone marrow stimulation (BMS) is indicated for patients who have symptomatic osteochondral lesions of the talus (OLT). Despite differences in ankle biomechanics and cartilage morphology between men and women, there is scant evidence examining whether these differences affect surgical outcomes. The purpose of this study was to compare the outcomes in men and women following BMS for OLTs. A retrospective analysis comparing female and male patients treated with BMS for OLT between 2007 and 2015 was performed. Clinical outcomes were eval-uated using the Foot and Ankle Outcome Scores (FAOS) and Short-Form 12 (SF-12). Magnetic resonance imaging at final follow-up was evaluated with the modified magnetic resonance observation of cartilage repair tissue score. Thirty-one females and 38 males were included. In female patients, the mean FAOS pain score improved from 60 +/- 16 preoperatively to 84 +/- 8.9 at 1-to 2-year follow-up (p < .01), and then decreased to 80 +/- 13 at final follow-up at 3-4 years. In male patients, the mean FAOS pain score improved from 65 +/- 17 preoperatively to 83 +/- 9.2 at 1-2 year follow-up (p < .01), and then decreased to 76 +/- 14.6 at final follow-up at 3-4 years. Lateral lesions were more com-mon in male patients. Medial lesions were more common in female patients. The outcomes following BMS in both female and male patients were good with no significant differences at short-term follow-up. FAOS scores in male patients were more likely to decrease after 1 to 2 years postsurgery, implying a possibly faster decline than in female patients.(c) 2022 by the American College of Foot and Ankle Surgeons. All rights reserved.